Amedisys (NASDAQ:AMED) edged lower by 1.2% after a judge tentatively set a date for the Dep. of Justice's challenge of ...
The probe is analyzing the company’s practice of frequently logging diagnoses that trigger larger payments to its Medicare ...
The U.S. Justice Department has launched an investigation into UnitedHealth's Medicare billing practices in recent months, ...
A sweeping fraud probe into UnitedHealth's Medicare Advantage payments sparks panic on Wall Street--Is this just the ...
Empowered Funds LLC bought a new stake in Amedisys, Inc. (NASDAQ:AMED – Free Report) during the fourth quarter, Holdings ...
Shares tumbled after The Wall Street Journal reported that the insurer is under Justice Department investigation.
A trial between the Justice Department and UnitedHealth Group Inc. over its proposed purchase of Amedisys Inc. will take place in October 2025, a Maryland federal judge ruled Thursday.
UnitedHealth Group and Amedisys outlined plans to divest a significant number of home health and hospice locations as they ...
UnitedHealth Group said in a court filing it is working with Amedisys to identify potential buyers for at least 128 home ...
Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. BATON ROUGE, La., ...